scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1053190579 |
P356 | DOI | 10.1038/SJ.ONC.1205066 |
P698 | PubMed publication ID | 11821945 |
P5875 | ResearchGate publication ID | 11538087 |
P50 | author | Mien-Chie Hung | Q1532952 |
P2093 | author name string | Brian Varnum | |
Yong Wen | |||
Wei-Ping Lee | |||
P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase | Q24310364 | ||
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade | Q24310383 | ||
Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6 | Q24313270 | ||
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
Phosphorylation and regulation of Raf by Akt (protein kinase B) | Q28138863 | ||
NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase | Q28144326 | ||
NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
Mitogenic activation, phosphorylation, and nuclear translocation of protein kinase Bbeta | Q28255046 | ||
Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt | Q28255373 | ||
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes | Q28265486 | ||
Signaling through the ARK tyrosine kinase receptor protects from apoptosis in the absence of growth stimulation | Q28589590 | ||
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase | Q29618387 | ||
Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction | Q29618388 | ||
Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products | Q33630332 | ||
Axl-gas6 interaction counteracts E1A-mediated cell growth suppression and proapoptotic activity | Q33960576 | ||
Tumor suppression activity of adenovirus E1a protein: anoikis and the epithelial phenotype | Q34061955 | ||
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases | Q34319294 | ||
The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding | Q36566375 | ||
Differential requirement for adenovirus type 12 E1A gene products in oncogenic transformation. | Q36784172 | ||
Transformation of NIH 3T3 cells by cotransfection with c-src and nuclear oncogenes | Q36922532 | ||
Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene | Q36961265 | ||
The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins | Q37162513 | ||
Antioncogenic effect of adenovirus E1A in human tumor cells | Q37605329 | ||
Requirement of phosphatidylinositol 3-kinase-dependent pathway and Src for Gas6-Axl mitogenic and survival activities in NIH 3T3 fibroblasts | Q40022933 | ||
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial | Q40599715 | ||
Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor | Q41067751 | ||
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. | Q41563742 | ||
HER-2/neu blocks tumor necrosis factor-induced apoptosis via the Akt/NF-kappaB pathway | Q42804558 | ||
Gas6-mediated survival in NIH3T3 cells activates stress signalling cascade and is independent of Ras. | Q42812461 | ||
Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture | Q43891070 | ||
Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo. | Q52532536 | ||
E1A sensitizes cells to tumor necrosis factor-induced apoptosis through inhibition of IkappaB kinases and nuclear factor kappaB activities | Q64381387 | ||
The erbB2 gene as a cancer therapeutic target and the tumor- and metastasis-suppressing function of E1A | Q64381899 | ||
GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells | Q74326161 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 329-336 | |
P577 | publication date | 2002-01-01 | |
P1433 | published in | Oncogene | Q1568657 |
P1476 | title | Akt is required for Axl-Gas6 signaling to protect cells from E1A-mediated apoptosis | |
P478 | volume | 21 |
Q37665524 | A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer |
Q42359111 | AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases |
Q38742188 | Anexelekto (AXL) Increases Resistance to EGFR-TKI and Activation of AKT and ERK1/2 in Non-Small Cell Lung Cancer Cells |
Q39490176 | Axl is a prognostic marker in oral squamous cell carcinoma |
Q39633320 | Axl promotes cutaneous squamous cell carcinoma survival through negative regulation of pro-apoptotic Bcl-2 family members. |
Q33916284 | Blockade of Axl signaling ameliorates HPV16E6-mediated tumorigenecity of cervical cancer |
Q42693450 | Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling |
Q64258088 | Dihydroartemisinin inhibits prostate cancer via JARID2/miR-7/miR-34a-dependent downregulation of Axl |
Q34564800 | Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule |
Q51672088 | Effects of extracellular acid stimulation on rat vascular smooth muscle cell in Gas6/Axl or PI3K/Akt signaling pathway. |
Q37118186 | Enhancing the clinical activity of granulocyte-macrophage colony-stimulating factor-secreting tumor cell vaccines |
Q36546044 | Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity. |
Q49636410 | Function of Axl receptor tyrosine kinase in non-small cell lung cancer |
Q90119561 | Gas6 attenuates lipopolysaccharide‑induced TNF‑α expression and apoptosis in H9C2 cells through NF‑κB and MAPK inhibition via the Axl/PI3K/Akt pathway |
Q38763966 | Gene of the month: Axl. |
Q38003815 | Growth arrest-specific gene 6 (gas6) and vascular hemostasis |
Q33265521 | Heterogeneity of mammary lesions represent molecular differences |
Q35125173 | Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma. |
Q45866974 | Insertional mutagenesis by replication-deficient retroviral vectors encoding the large T oncogene |
Q64378213 | Involvement of Bcl-X(L) deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells |
Q39157476 | Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies |
Q36461930 | Negative feedback regulation of AXL by miR-34a modulates apoptosis in lung cancer cells |
Q92717407 | Overcoming the Intrinsic Gefitinib-resistance via Downregulation of AXL in Non-small Cell Lung Cancer |
Q91292042 | PTBP1-mediated regulation of AXL mRNA stability plays a role in lung tumorigenesis |
Q55345918 | Potential Molecular Signatures Predictive of Lung Cancer Brain Metastasis. |
Q34451033 | Promotion of glioblastoma cell motility by enhancer of zeste homolog 2 (EZH2) is mediated by AXL receptor kinase |
Q24540107 | RETRACTED: A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control |
Q39592978 | Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer |
Q35923996 | Regulation of the activity of p38 mitogen-activated protein kinase by Akt in cancer and adenoviral protein E1A-mediated sensitization to apoptosis |
Q38720434 | Role of AXL expression in non-small cell lung cancer |
Q34794927 | TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer |
Q34545399 | TWIST1 drives cisplatin resistance and cell survival in an ovarian cancer model, via upregulation of GAS6, L1CAM, and Akt signalling |
Q35927501 | Taking aim at Mer and Axl receptor tyrosine kinases as novel therapeutic targets in solid tumors |
Q35832938 | Targeting the degradation of AXL receptor tyrosine kinase to overcome resistance in gefitinib-resistant non-small cell lung cancer |
Q34515144 | The Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinoma |
Q28068756 | The Receptor Tyrosine Kinase AXL in Cancer Progression |
Q54298179 | The TAM family: phosphatidylserine sensing receptor tyrosine kinases gone awry in cancer. |
Q38185905 | The anti-tumor activity of E1A and its implications in cancer therapy |
Q39381139 | The receptor tyrosine kinase Axl is an essential regulator of prostate cancer proliferation and tumor growth and represents a new therapeutic target. |
Q61810968 | Transcatheter arterial embolization combined with hypoxia-replicative oncolytic adenovirus perfusion enhances the therapeutic effect of hepatic carcinoma |
Q28509359 | Twist mediates suppression of inflammation by type I IFNs and Axl |
Q24295256 | Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts |
Q37122103 | Vitamin K-dependent actions of Gas6. |
Search more.